Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

124.52
Delayed Data
As of Jun 20
 +2.61 / +2.14%
Today’s Change
102.10
Today|||52-Week Range
149.34
+4.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues2.2B2.5B3.0B3.5B
 
 
 
 
 
Cost of Goods Sold146.1M203.5M194.0M134.7M
 
 
 
 
 
Depreciation And Amortization46.9M160.2M386.0M487.5M
 
 
 
 
 
 
Operating ExpensesGross Income2.0B2.1B2.4B2.9B
 
 
 
 
 
General Expenses1.1B1.6B1.7B1.9B
 
 
 
 
 
Research And Development499.7M695.4M757.0M862.1M
 
 
 
 
 
Total Operating Expenses1.3B1.9B2.3B2.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income891.9M564.4M720.0M964.6M
 
 
 
 
 
Extraordinary Credit34.2M0.000.00--
 
 
Extraordinary Charge-47.2M-145.6M-126.0M-358.5M
 
 
 
 
 
Interest Expense On Debt3.0M47.7M97.0M97.3M
 
 
 
 
 
Other Expenses-12.2M118.7M68.0M20.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income872.1M498.1M576.0M547.8M
 
 
 
 
 
Income Taxes-215.2M-353.8M-177.0M-104.5M
 
 
 
 
 
Net Income656.9M144.4M399.0M443.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS198.1M213.4M224.0M223.9M
 
 
 
 
 
Shares To Calculate EPS Diluted201.6M215.9M227.0M225.4M
 
 
 
 
 
 
Earnings Per ShareEPS$3.26$0.67$1.76$1.97
 
 
 
 
 
EPS Diluted$3.26$0.67$1.76$1.97